Keywords: sanofi-aventis, beats, world, market, growth, 1st-qtr, sales
Sanofi-Aventis beats world market growth with 1st-qtr sales up 11.9%
Article | 23 May 2005
France's Sanofi-Aventis, the world's third-largest drugmaker, has posted strong first-quarter 2005 results with turnover of 6.42 billion euros ($8.23 billion), up 8.4% or 11.9% higher ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
